Hao, Zikai
Meng, Chen
Li, Leyuan
Feng, Siyuan
Zhu, Yinzhen
Yang, Jianlou
Han, Liangzhe
Sun, Leilei
Lv, Weifeng
Figeys, Daniel
Liu, Hong
Article History
Received: 10 February 2022
Accepted: 24 February 2023
First Online: 24 April 2023
Declarations
:
: This study was approved by the biomedical ethics committee of Beihang University (Approval number: BM20180003 and BM20210108).
: All authors gave their consent for publications.
: Daniel Figeys is co-founder of MedBiome Inc. a company that develops nutritional and therapeutic approaches targeting the gut microbiome. All other authors declare no competing interests.